Detalhe da pesquisa
1.
A Phase 2a Randomized Study to Evaluate the Safety and Immunogenicity of the 1790GAHB Generalized Modules for Membrane Antigen Vaccine against Shigella sonnei Administered Intramuscularly to Adults from a Shigellosis-Endemic Country.
Front Immunol
; 8: 1884, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29375556